1-1 of 1
Rachel van Swelm, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of the Hepcidin Antagonist PRS-080#022. Results from a Randomized, Placebo Controlled, Double-Blind Study Following Single Administration to Healthy Subjects a

Ulrich Moebius, PhD, Werner Feuerer, MD, Edgar Fenzl, MD, Rachel van Swelm, PhD, Dorine W. Swinkels, MD PhD, Andreas Hohlbaum, PhD
Journal: Blood
Blood (2015) 126 (23): 536.
https://doi.org/10.1182/blood.V126.23.536.536
Published: 2015